NAD+ Supplements Show Promise in Animals But Mixed Results in Human Anti-Aging Studies
Comprehensive review of 113 studies reveals NAD+ precursors are safe but clinical benefits for longevity remain unclear.
Summary
A major systematic review of 113 studies found that NAD+ supplements like NR and NMN consistently raise NAD+ levels in humans and are generally safe, but their anti-aging benefits remain unclear. While animal studies showed promising improvements in metabolism, mitochondrial function, and inflammation, human trials produced mixed results with many showing no meaningful effects on healthspan markers. The supplements did demonstrate clear biological activity by increasing NAD-related compounds in blood and cells over weeks to months of use. However, effects on functional outcomes like physical performance, metabolic health, and vascular function were inconsistent or absent in most human studies.
Detailed Summary
NAD+ levels naturally decline with age, driving interest in supplements that could restore this crucial cellular molecule and potentially slow aging. This comprehensive systematic review analyzed 113 peer-reviewed studies from 2010-2025 to evaluate whether NAD+ supplementation delivers on its anti-aging promises.
Researchers examined 33 human studies and 80 animal studies testing NAD+ precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), plus some intravenous NAD+ protocols. The human studies included 28 randomized controlled trials spanning weeks to months of supplementation.
The results paint a nuanced picture. In rodent models, NAD+ boosting consistently improved metabolic function, mitochondrial health, inflammation markers, and physical performance. However, human studies told a different story. While NR and NMN supplements reliably increased NAD-related compounds in blood and cells, proving they work biochemically, their effects on meaningful health outcomes were disappointing. Most studies found no significant improvements in physical function, metabolic markers, or cardiovascular health.
For longevity enthusiasts, this suggests NAD+ supplements may not be the anti-aging breakthrough many hoped for, at least based on current evidence. The supplements appear safe for regular use, but their clinical benefits remain unproven. The research gap is particularly notable for IV NAD+ treatments popular in wellness clinics, which lack rigorous safety and efficacy data. Larger, longer-term studies with clinically meaningful endpoints are needed before NAD+ supplementation can be confidently recommended for anti-aging purposes.
Key Findings
- NAD+ precursors NR and NMN reliably increase cellular NAD+ levels but show inconsistent anti-aging benefits
- Animal studies show promising metabolic and mitochondrial improvements that don't translate to humans
- Oral NAD+ supplements appear safe for weeks to months of use with minimal side effects
- IV NAD+ treatments lack rigorous clinical evidence despite popularity in wellness settings
- Larger, longer-term human trials needed to determine true anti-aging potential
Methodology
PRISMA-guided systematic review of 113 studies (33 human, 80 rodent) from January 2010-October 2025. Human studies included 28 randomized controlled trials and 5 nonrandomized studies evaluating oral and parenteral NAD+ compounds over weeks to months.
Study Limitations
Most human studies were relatively short-term with small sample sizes. Limited data on optimal dosing, long-term safety, and virtually no rigorous evidence for popular IV NAD+ protocols used in wellness clinics.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.